The board of directors of Sino Biopharmaceutical Limited announced that the randomised, open, positive drug-parallel controlled, multi-centre Phase III clinical study for the first-line treatment of.
Tivozanib Shows Benefits in Long-Term Survival for Relapsed/Refractory Renal Cell Carcinoma pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.